Catinazzo Thomas 4
4 · Relay Therapeutics, Inc. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-28$3.74/sh−1,701$6,362→ 353,675 total - Sale
Common Stock
2025-07-29$3.68/sh−18,380$67,638→ 335,295 total
Footnotes (4)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,724 shares of restricted stock units ("RSUs") on July 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 200,516 shares underlying RSUs.
- [F3]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,393 shares of RSUs on July 28, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F4]Includes 158,123 shares underlying RSUs.